S. Korean Firm, Russia’s RDIF Agree on Sputnik V Vaccine Tech Tranfer

SEOUL, April 15 (Korea Bizwire) — South Korean bio-tech company Isu Abxis said Thursday that a technology transfer deal with Russia’s sovereign wealth fund will pave the way for it to produce Sputnik V COVID-19 vaccine soon. Under the agreement with Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF), and local bio firm GL [...]